Evidence map›Paper›PMID 32545382›Full record

ReviewCells2020

Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?

Michela Mocchi, Silvia Dotti, Maurizio Del Bue, Riccardo Villa, Elia Bari, Sara Perteghella, Maria Luisa Torre, Stefano Grolli

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Regenerative strategies for intervertebral disc degeneration.Journal of orthopaedic translation · 2025
    Review
  8. Mesenchymal Stem Cells in Veterinary Medicine-Still Untapped Potential.Animals : an open access journal from MDPI · 2025
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Michela MocchiDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy.
Silvia DottiIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy.
Maurizio Del BueFreelance Veterinary Medical Doctor, 43121 Parma, Italy.
Riccardo VillaIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy.
Elia BariDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy.ORCID 0000-0003-0241-0620
Sara PerteghellaDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy.ORCID 0000-0003-1128-7636
Maria Luisa TorreDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy.ORCID 0000-0001-8062-6836
Stefano GrolliDepartment of Veterinary Medical Science, University of Parma, 43121 Parma, Italy.ORCID 0000-0003-4380-5725
University of Pavia · ITIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna "Bruno Ubertini" · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regenerative medicine aims to restore the normal function of diseased or damaged cells, tissues, and organs using a set of different approaches, including cell-based therapies. In the veterinary field, regenerative medicine is strongly related to the use of mesenchymal stromal cells (MSCs), which belong to the body repair system and are defined as multipotent progenitor cells, able to self-replicate and to differentiate into different cell types. This review aims to take stock of what is known about the MSCs and their use in the veterinary medicine focusing on clinical reports on dogs and horses in musculoskeletal diseases, a research field extensively reported in the literature data. Finally, a perspective regarding the use of the secretome and/or extracellular vesicles (EVs) in the veterinary field to replace parental MSCs is provided. The pharmaceuticalization of EVs is wished due to the realization of a Good Manufacturing Practice (GMP product suitable for clinical trials.

Indexed as

Regenerative MedicineVeterinary MedicineAnimalsCryopreservationDisease Models, AnimalMesenchymal Stem CellsMusculoskeletal Diseasesexosomesextracellular vesiclesmesenchymal stem cellsmicrovesiclesregenerative medicinesecretomeveterinary

Identifiers

PMID32545382
PMCPMC7349187
OpenAlexW3034564443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.